Rockwell Medical Technologies (RMTI) Announces Proposed Common Share Offering

Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced an underwritten public offering of its common stock. In addition, Rockwell Medical has granted the underwriter a 30-day option to purchase up to an additional 15% of the number of shares of its common stock offered in the public offering.

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.

Rockwell Medical anticipates using the net proceeds from the offering for the commercialization of Dialysate Triferic and I.V. Triferic, research and development and general corporate purposes.

You May Also Be Interested In

• Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
• CrowdStrike (CRWD) Reiterated at Overweight by Cantor Fitzgerald as CEO Departs
• Cantor Fitzgerald Starts Nuvectis Pharma (NVCT) at Overweight